Prevalence of Undiagnosed Type-2-Diabetes Mellitus and Impaired Fasting Glucose in German Primary Care: Data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)

Abstract

Aims: Primary care physicians are gatekeepers of the healthcare system and thus responsible for screening, prevention and treatment of diabetes. Little is known about the prevalence of diabetes, impaired fasting glucose and factors that are associated with the risk of future development of diabetes and subsequent cardiovascular disease in unselected patients presenting to general practitioners.

Research Design and Methods: A nationwide sample of 35,869 primary care patients screened in 2005 was used to estimate the prevalence of detected and undetected diabetes as well as of impaired fasting glucose. Logistic regressions were used to assess the prevalence, cardiovascular morbidity and the factors associated with undetected diabetes and impaired fasting glucose.

Results: 1) Using a blood glucose screening algorithm the prevalence of known type 1 and type 2 diabetes mellitus was found to be 0.6 and 12.2%, respectively. Another 2.9% (23% of the diagnosed) had either undiagnosed diabetes (0.9%) or impaired fasting glucose (2.0%). 2) Undiagnosed patients had a more unfavourable cardiovascular risk profile compared to non-diabetic patients. 3) Moreover, higher age, male gender, low HDL-cholesterol and elevated triglycerides as well as a family history of diabetes were associated with unknown diabetes or impaired fasting glucose.

Conclusions: Approximately 15.7% of individuals in Germany consulting a primary care physician are affected from either diabetes (known and unknown) or impaired fasting glucose and face a substantially elevated cardiovascular risk score. This study demonstrated that using a simplified blood glucose screening algorithm considering risk markers like higher age, male gender, low HDL-cholesterol, high triglycerides and a family history of diabetes may well serve as a suitable screening approach for undiagnosed diabetes and impaired fasting glucose in primary care practice.

Key words

impaired fasting glucose - epidemiology - prevalence - cardiovascular risk - prevention

References

• 1 Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition.  Lancet. 2005;  366 1059-1062
• 2 Balkau B. The DECODE study. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe.  Diabetes Metab. 2000;  26 282-286
• 3 Balkau B, Vernay M, Mhamdi L. et al . The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study.  Diabetes Metab. 2003;  29 526-532
• 4 Christensen JO, Sandbaek A, Lauritzen T, Borch-Johnsen K. Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms.  Diabetologia. 2004;  47 1566-1573
• 5 Danaei G, Lawes CM, Vander Hoorn S, Murray CJ, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment.  Lancet. 2006;  368 1651-1659
• 6 Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions.  Diabetes Care. 2003;  26 575-581
• 7 Franse LV, Di Bari M, Shorr RI. et al . Type 2 diabetes in older well-functioning people: who is undiagnosed? Data from the health, aging, and body composition study.  Diabetes Care. 2001;  24 2065-2070
• 8 Gaede P, Vedel P, Larsen N. et al . Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.  N Engl J Med. 2003;  348 383-393
• 9 Grundy SM, Cleeman JI, Daniels SR. et al . Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.  Circulation. 2005;  112 2735-2752
• 10 Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.  N Engl J Med. 1998;  339 229-234
• 11 Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a US perspective.  Diabetes Metab Res Rev. 2000;  16 230-236
• 12 Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis.  Diabetes Care. 1992;  15 815-819
• 13 Hauner H. Occurrence of diabetes mellitus in Germany.  Dtsch Med Wochenschr. 1998;  123 777-782
• 14 Hauner H, Koster I, Ferber L von. Prevalence of diabetes mellitus in Germany 1998-2001. Secondary data analysis of a health insurance sample of the AOK in Hessen/KV in Hessen.  Dtsch Med Wochenschr. 2003;  128 2632-2637
• 15 Isomaa B, Almgren P, Tuomi T. et al . Cardiovascular morbidity and mortality associated with the metabolic syndrome.  Diabetes Care. 2001;  24 683-689
• 16 Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.  Diabetes Care. 2005;  28 2289-2304
• 17 Krone W, Böhm M. Erhebung und Verbesserung der Behandlungssituation von Patienten mit Diabetes mellitus. Das DUTY-Register.  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004;  47 540-546
• 18 Lakka HM, Laaksonen DE, Lakka TA. et al . The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.  JAMA. 2002;  288 2709-2716
• 19 Lawrence JM, Bennett P, Young A, Robinson AM. Screening for diabetes in general practice: cross sectional population study.  BMJ. 2001;  323 548-551
• 20 Lehnert H, Wittchen HU, Pittrow D. et al . Prevalence and pharmacotherapy of diabetes mellitus in primary care.  Dtsch Med Wochenschr. 2005;  130 323-328
• 21 Lieberman LS. Dietary, evolutionary, and modernizing influences on the prevalence of type 2 diabetes.  Annu Rev Nutr. 2003;  23 345-377
• 22 Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk.  Diabetes Care. 2003;  26 725-731
• 23 Löwel H, Stieber J, Koenig W. et al . The diabetes-related risk of myocardial infarction in a southern German population: results of the MONICA Augsburg studies 1985-1994.  Diab Stoffw. 1999;  8 11-21
• 24 MacAuley KA, Williams SM, Mann JI. et al . Diagnosing insulin resistance in the general population.  Diabetes Care. 2001;  24 460-464
• 25 Moebus S, Hanisch JU, Neuhäuser M. et al . Assessing the Metabolic Syndrome according to NCEP ATP III in Germany: Feasibility of a two step approach in 1 550 randomly selected primary health care practices.  GMS. 2006;  4 , Doc7 (20061009)
• 26 Pittrow D, Stalla GK, Zeiher AM. et al . Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care.  Med Klin (Munich). 2006;  101 635-644
• 27 Rathmann W, Haastert B, Icks A. et al . High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening.  The KORA survey 2000. , Diabetologia 2003;  46 182-189
• 28 SAS9.1 .>In. Release 9.1 ed. Cary NC: SAS Institute Inc. 2005
• 29 Sattar N, Gaw A, Scherbakova O. et al . Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.  Circulation. 2003;  108 414-419
• 30 Scherbaum WA, Dicken HD, Verheyen F, Baehring T. Detection of a previously unrecognized type 2 diabetes using a risk questionnaire. Efficiency for general population screening.  Dtsch Med Wochenschr. 2006;  131 2208-2212
• 31 Schulze J, Rothe U, Muller G, Kunath H. Improvement of care for diabetics using the care model from Saxony.  Dtsch Med Wochenschr. 2003;  128 1161-1166
• 32 Thefeld W. Prevalence of diabetes mellitus in the adult German population.  Gesundheitswesen. 1999;  61 , Spec No:S85-89
• 33 UKPDS . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38.  BMJ. 1998;  317 703-713
• 34 UKPDS. . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).  Lancet. 1998;  352 837-853
• 35 Uusitupa M, Siitonen O, Aro A, Pyorala K. Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects.  Diabetologia. 1985;  28 22-27
• 36 Wareham NJ, Griffin SJ. Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria.  BMJ. 2001;  322 986-988
• 37 WHO . Definition, diagnosis and classification of diabetes mellitus and its complications.  , Report of a WHO Consultation. Part 1: Diagnosis and classification of diabetes mellitus 1999; 

Correspondence